Ilya M. Rachman - 14 Nov 2022 Form 4 Insider Report for Immix Biopharma, Inc. (IMMX)

Role
CEO and Chairman, Director
Signature
/s/ Ilya Rachman
Issuer symbol
IMMX
Transactions as of
14 Nov 2022
Net transactions value
+$5,225
Form type
4
Filing time
15 Nov 2022, 16:33:14 UTC
Previous filing
18 Jul 2022
Next filing
14 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMMX Common Stock Purchase $4,127 +4,050 +0.45% $1.02 906,550 14 Nov 2022 Direct
transaction IMMX Common Stock Purchase $950 +1,000 +0.11% $0.9500 907,550 14 Nov 2022 Direct
transaction IMMX Common Stock Purchase $148 +150 +0.02% $0.9900 907,700 14 Nov 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.